CVS Group plc Exercise of Options & Total Voting Rights (1620W)
06 February 2017 - 5:25PM
UK Regulatory
TIDMCVSG
RNS Number : 1620W
CVS Group plc
06 February 2017
6 February 2017
CVS Group plc
("CVS" or the "Company")
Exercise of Options and Total Voting Rights
CVS, one of the UK's leading providers of integrated veterinary
services for small and large animals, announces that 19,587
ordinary shares of 0.2 pence each ("Ordinary Shares") (the "SAYE
Shares") were issued on 2 February 2017 as a result of the exercise
of employee share options, in connection with the Company's
2013/2016 Save As You Earn Scheme.
The SAYE Shares rank pari passu with all existing Ordinary
Shares. The issue of the SAYE Shares has been satisfied via the
Company's block listing which was announced on 19 December
2016.
The Company also announces that 2,277 Ordinary Shares of 0.2
pence each (the "New Shares") were allotted on 2 February 2017 as a
result of the exercise of employee share options by former
employees, in connection with the Company's 2014/2017 Save As You
Earn Scheme and the Company's 2015/2018 Save As You Earn Scheme.
Application has been made for the New Shares, which rank pari passu
in all respects with the Company's existing Ordinary Shares, to be
admitted to trading on AIM which is expected to occur on or around
13 February 2017.
Following issue of the SAYE and New Shares, the Company's total
issued share capital will consist of 63,851,424 Ordinary Shares
with one voting right per share. The Company does not hold any
Ordinary Shares in Treasury. Therefore, following the issue of SAYE
Shares, the total number of voting rights in the Company is
63,851,424. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
Contacts:
CVS Group plc Tel: 01379 644
Simon Innes, Chief Executive 288
Nick Perrin, Finance Director
N+1 Singer (Nominated Adviser Tel: 020 7496
& Broker) 3000
Aubrey Powell
Liz Yong
James Hopton
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOELLFFDFIIRIID
(END) Dow Jones Newswires
February 06, 2017 12:25 ET (17:25 GMT)